Specialty biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) Friday introduced first-quarter 2024 monetary outcomes, reporting a decline in adjusted earnings and a modest rise in revenues.
The corporate reported worldwide internet revenues of $12.31 billion for the March quarter, up 1% from the corresponding interval of 2023. Declines in Immunology and Aesthetics revenues have been greater than offset by progress within the different key segments.
Internet revenue, adjusted for particular objects, declined to $2.31 per share in Q1 from $2.46 per share within the year-ago quarter. On a reported foundation, fourth-quarter revenue was $1.37 billion or $0.77 per share, in comparison with $239 million $0.13 per share final 12 months.
